Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats

Acta Histochemica

Volumn 109, Issue 4, 2007, Pages 304-314

  Altan, Mehmet Fatih ^a   Kanter, Mehmet ^b   Donmez, Senayi ^c   Kartal, Murat Emre ^a   Buyukbas, Sadik ^d  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

^d SELCUK UNIVERSITY   (Turkey)

Author keywords

Bone histomorphometry; Diabetes mellitus; Human parathyroid hormone; Nigella sativa; Pancreatic cells; Rat; Streptozotocin

Indexed keywords

ANTIBIOTICS; IMMUNOLOGY; INSULIN; MEDICAL PROBLEMS; RATS; SEED;

BONE HISTOMORPHOMETRY; HERBACEOUS PLANTS; NIGELLA SATIVA; STREPTOZOTOCIN;

CHEMOTHERAPY;

INSULIN; NIGELLA SATIVA EXTRACT; PARATHYROID HORMONE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BLACK CUMIN; BONE MASS; BONE TISSUE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMUR; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MONOTHERAPY; MORPHOMETRICS; NONHUMAN; OSTEOPENIA; PANCREAS ISLET; PANCREAS ISLET BETA CELL; RAT; STREPTOZOCIN DIABETES; TREATMENT OUTCOME;

NIGELLA SATIVA; RANUNCULACEAE; RATTUS;

EID: 34250729777     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2007.02.006     Document Type: Article

References (68)

1. Al-Hader A., Aqel M., and Hasan Z. Hypoglycemic effects of the volatile oil of Nigella sativa seeds. Int J Pharmacognosy 31 (1993) 96-100
2. Ar'Rajab A., and Ahrtn B. Long-term diabetogenic effect of streptozotocin in rats. Pancreas 8 (1993) 50-57
3. Auwerx J., Dequeker J., Bouillon R., Geusens P., and Nijs J. Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus. Diabetes 37 (1988) 8-12
4. Baker D., Roberts R., and Towell T. Factors predictive of bone mineral density in eating-disordered women: a longitudinal study. Int J Eat Disord 27 (2000) 29-35
5. Baumann B.D., and Wronski T.J. Response of cortical bone to anti-resorptive agents and PTH in aged ovariectomized rats. Bone 16 (1995) 247-253
6. Baynes J.W., and Thorpe S.R. The role of oxidative stress in diabetic complications. Curr Opin Endocrinol 3 (1996) 277-284
7. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 (1991) 405-412
8. Bhattacharya G. On the protection against alloxan diabetes by hexoses. Science 120 (1954) 841-843
9. Cheng P.T., Chan C., and Muller K. Cyclical treatment of osteopenic ovariectomized adult rats with PTH (1-34) and pamidronate. J Bone Miner Res 10 (1995) 119-126
10. Coskun O., Ocakci A., Bayraktaroglu T., and Kanter M. Exercise training prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Tohoku J Exp Med 203 3 (2004) 145-154
11. Damasceno D.C., Volpato G.T., Paranhos-Calderon M., and Cunha-Rudge M.V. Oxidative stress and diabetes in pregnant rats. Anim Reprod Sci 15 (2002) 235-244
12. Dixit P.K., and Ekstrom R.A. Decreased breaking strength of diabetic rat bone and its improvement by insulin treatment. Calcif Tissue Int 32 (1980) 195-199
13. Dobnig H., and Turner R.T. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 138 (1997) 4607-4612
14. Ekeland A., Engesaeter L.B., and Langeland N. Mechanical properties of fractured and intact rat femora evaluated by bending, torsional, and tensile tests. Acta Orthop Scand 52 (1981) 605-613
15. El-Dakhakhny M., Mady N., Lembert N., and Ammon H.P. The hypoglycemic effect of Nigella sativa oil is mediated by extrapancreatic actions. Planta Med 68 (2002) 465-466
16. El-Daly E.S. Protective effect of cysteine and vitamin E, Crocus sativus and Nigella sativa extracts on cisplatin-induced toxicity in rats. J Pharm Belg 53 (1998) 87-93
17. El-Kadi A., and Kandil O. The black seed (Nigella sativa) and immunity: its effect on human T cell subset. Fed Proc 46 (1987) 1222
18. El-Shabrawy O.A., and Nada S.A. Biological evaluation of multicomponent tea used as hypoglycemic in rats. Fitoterapia 67 (1996) 99-102
19. El-Tahir K.E.H., Al-Harbi M.M.S., and Ashour M.M. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. Gen Pharmacol 24 (1993) 1123-1131
20. Fararh K.M., Atoji Y., Shimizu Y., and Takewaki T. Insulinotropic properties of Nigella sativa oil in streptozotocin plus nicotinamide diabetic hamster. Res Vet Sci 73 (2002) 279-282
21. Gillery P., Monboisse J.C., Maquart F.X., and Borel J.P. Does oxygen free radical increased formation explain long-term complications of Diabetes mellitus?. Med Hypotheses 29 (1989) 47-50
22. Gul M., Laaksonen D.E., and Atalay M. Effects of endurance training on tissue glutathione homeostasis and lipid peroxidation in streptozotocin-induced diabetic rats. Scand J Med Sci Sports 12 (2002) 63-170
23. Gunczler P., Lanes R., Paoli M., Martinez V., Villarel O., and Weisinger J.R. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab 14 (2001) 525-528
24. Gunness-Hey M., and Hock J.M. Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis Relat Res 5 (1984) 177-181
25. Hales C.N., and Randle P.J. Immunoassay of insulin with insulin-antibody precipitate. Biochem J 88 (1963) 137-146
26. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. third ed (1999), Oxford University Press, Oxford, UK
27. Hammers H.D., Martin S., Fedesrlin K., Geisen K., and Brownlle M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88 (1991) 11555-11558
28. Hock J.M., Gera I., Fonesca J., and Raisz L.G. Human PTH increases rat bone mass in ovariectomized and orchidectomized rats. Endocrinology 122 (1998) 2899-2904
29. Houghton P.J., Zarka R., de las Heras B., and Hoult J.R. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61 (1995) 33-36
30. Hsu S.M., Raine L., and Fanger H. Use of Avidin-Biotin-Peroxidase complex (ABC) in immunperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29 (1981) 577-580
31. Jilka R.I., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., and Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with PTH. J Clin Invest 104 (1999) 439-446
32. Johnson S.R. How serious a problem is postmenopausal osteoporosis?. Univ Iowa Health Care 3 (2002) 3
33. Kanter M., Coskun O., Korkmaz A., and Oter S. Effects of Nigella sativa on oxidative stress and beta-cell damage in streptozotocin-induced diabetic rats. Anat Rec A Discov Mol Cell Evol Biol 279 (2004) 685-691
34. Kanter M., Meral I., Yener Z., Ozbek H., and Demir H. Partial regeneration/proliferation of the beta-cells in the islets of Langerhans by Nigella sativa L. in streptozotocin-induced diabetic rats. Tohoku J Exp Med 201 (2003) 213-219
35. Klibanski A., Biller B.M.K., Shoenfeld D.A., Herzog D.B., and Saxe V.C. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 80 (1995) 898-904
36. Kronenberg H.M., Lanske B., Kovacs C.S., Chung U.I., Lee K., Segre G.V., et al. Functional analysis of the PTH/PTHrP network of ligands and receptors. Recent Prog Horm Res 53 (1998) 283-301
37. Kunjathoor V., Wilson D., and LeBoeuf R. Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97 (1996) 1767-1773
38. Lesclous P., Guez D., and Saffar J.L. Short-term prevention of osteoclastic resorption and osteopenia in ovariectomized rats treated with the H-2 receptor antagonist cimetidine. Bone 30 (2002) 131-136
39. Matkovics B., Kotorman M., Varga I.S., Hai D.Q., and Varga C. Oxidative stress in experimental diabetes induced by streptozotocin. Acta Physiol Hung 85 (1997-1998) 29-38
40. Mattila P.T., Knuuttila M.L., and Svanberg M.J. Dietary xylitol supplementation prevents osteoporotic changes in streptozotocin-diabetic rats. Metabolism 47 (1998) 578-583
41. Merzouk H., Madani S., and Chabane D. Time course of changes in serum glucose, insulin, lipids and tissue lipase activities in macrosomic offspring of rats with streptozotocin-induced diabetes. Clin Sci 98 (2000) 21-30
42. Morley P., Whitfield J.F., and Willick G.E. Anabolic effects of PTH on bone. Trends Endocrinol Metab 8 (1997) 225-231
43. Mosci P., Vecchiarelli A., Cenci E., Puliti M., and Bistoni F. Low-dose streptozotocin-induced diabetes in mice. Cell Immunol 150 (1993) 7-35
44. Mosekilde L., Danielsen C.C., Sogaard C.H., and Thorling E. The effect of long-term exercise on vertebral and femoral bone mass, dimensions, and strength assessed in a rat model. Bone 15 (1994) 293-301
45. Mosekilde L., Sogaard C.H., Danielsen C.C., Tørring O., and Nilsson M.H.L. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH(1-34) and hPTH(1-84). Endocrinology 129 (1991) 421-428
46. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344 (2001) 1434-1441
47. Parfitt A.M., Mathews C.H.E., Villanueva A.R., Kleerekoper M., Frame B., and Rao D.S. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis: implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72 (1983) 1396-1409
48. Passey R.B., Gillum R.F., Fuller J.B., Urry F.M., and Giles M.L. Evaluation and comparison of 10 glucose methods and the reference method recommended in the proposed product class standard (1974). Clin Chem 23 (1977) 131-139
49. Peng Z., Tuukkanen J., Zhang H., Jamsa T., and Vaananen H.K. The mechanical strength of bone in different rat models of experimental osteoporosis. Bone 15 (1994) 523-532
50. Pritchard K.A., Patel S.T., Karpen C.W., Newman H.A., and Panganamala R.V. Triglyceride-lowering effect of dietary vitamin E in streptozotocin-induced diabetic rats. Increased lipoprotein lipase activity in livers of diabetic rats fed high dietary vitamin E. Diabetes 35 (1986) 278-281
51. Rakieten N., Rakieten M.L., and Nadkarni M.V. Studies on the diabetogenic action of streptozotocin. Cancer Chemother Rep 29 (1963) 91-98
52. Reid I.R. Therapy of osteoporosis: calcium, vitamin D, and exercise. Am J Med Sci 312 (1996) 278-286
53. Rigotti N.A., Neer R.M., Skates S.J., Herzog D.B., and Nussbaum S.R. The clinical course of osteoporosis in anorexia nervosa. JAMA 265 (1991) 1133-1138
54. Sato T., and Sato K. The effects of intermittent administration of human parathyroid hormone (1-34) on streptozotocin-induced diabetic rats. J Bone Miner Metab 15 (1997) 145-150
55. Schein P.S., Cooney D.A., McMenamin M.G., and Anderson T. Streptozotocin diabetes - further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver. Biochem Pharmacol 15 (1973) 2625-2631
56. Schenk R.K., Olah A.J., and Herrmann W. Preparation of calcified tissues for light microscopy. In: Dickson G.R. (Ed). Methods of calcified tissues preparation (1984), Elsevier, Amsterdam 1-56
57. Schneider L.E., and Schedl H.P. Diabetes and intestinal calcium absorption the rat. Am J Physiol 223 (1972) 1319-1323
58. Seino Y., and Ishida H. Diabetic osteopenia: pathophysiology and clinical aspects. Diab Metab Rev 11 (1995) 21-35
59. Seven A., Guzel S., Seymen O., Civelek S., Bolayirli M., Yigit G., et al. Nitric oxide synthase inhibition by L-NAME in streptozotocin induced diabetic rats: impacts on oxidative stress. Tohoku J Exp Med 99 (2003) 205-210
60. Spencer E.M., Khalil M., and Tobiassen O. Experimental diabetes in the rat causes an insulin-reversible decrease in renal 25-hydroxyvitamin D3-1alfa-hyroxylase activity. Endocrinology 107 (1980) 300-305
61. Stavic B. Role of chemopreventers in human diet. Clin Biochem 27 (1994) 319-332
62. Tsuchida T., Miyakoshi N., Kudo T., Tamura Y., Kasukawa Y., Suzuki K., et al. Restoring effect of human parathyroid hormone (1-34) on trabecular connectivity in ovariectomized rats. Tohoku J Exp Med 194 (2001) 213-221
63. Tsuchida T., Sato K., Miyakoshi N., Abe T., Kudo T., Tamura Y., et al. Histomorphometric evaluation of the recovering effect of human parathyroid hormone (1-34) on bone structure and turnover in streptozotocin-induced diabetic rats. Calcif Tissue Int 66 (2000) 229-233
64. Weiss R.E., and Reddi A.H. Influence of experimental diabetes and insulin on matrix-induced cartilage and bone differentiation. Am J Physiol 238 (1980) E200-E207
65. Wolf E., Röser K., Hahn M., Welkerling H., and Delling G. Enzyme and immunohistochemistry on undecalcified bone and bone marrow biopsies after embedding in plastic: a new embedding method for routine application. Virchows Arch A Pathol Anat 420 (1992) 17-24
66. Wong K.K., and Tzeng E.S.F. Appearance of different diabetic symptoms after streptotozocin administration: a comparison study. Biochem Mol Biol Int 30 (1993) 1035-1041
67. Wu K., Schubeck K.E., Frost H.M., and Villanueva A. Haversian bone formation rates determined by a new method in a mastodon, and in human diabetes mellitus and osteoporosis. Calcif Tissue Res 6 (1970) 204-219
68. Yoshida O., Inaba M., Terada M., Shioi A., Nishizawa Y., Otani S., et al. Impaired response of human osteosarcoma (MG-63) cells to human parathyroid hormone induced by sustained exposure to high glucose. Miner Electrolyte Metab 21 (1995) 201-204